Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells. (Q39080574)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 December 2013
edit
Language Label Description Also known as
English
Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells.
scientific article published on 11 December 2013

    Statements

    Naringin inhibits ROS-activated MAPK pathway in high glucose-induced injuries in H9c2 cardiac cells (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit